SEC Filings

Filing date Description Form Filing Group View

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Form of prospectus reflecting facts events constituting substantive change from last form

424B3
Registration Statements
View HTML

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
View HTML

Additional proxy soliciting materials - definitive

DEFA14A
Proxy Filings
View HTML

An amendment to the SC 13G filing

SC 13G/A
Other
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Form of prospectus reflecting facts events constituting substantive change from last form

424B3
Registration Statements
View HTML

EFFECT

EFFECT
Other
View HTML

Data provided by Kaleidoscope.

Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.